Loading market dashboard
Cogent Biosciences, Inc.
COGTHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Cogent Biosciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.74B | $602.11M - $3.69B | $0.00 | $4.367 | 5 |
| Dec 2029 | $1.30B | $452.12M - $2.77B | $0.00 | $2.728 | 5 |
| Dec 2028 | $730.09M | $730.09M - $730.09M | $0.00 | $0.772 | 10 |
| Dec 2027 | $345.32M | $135.03M - $671.83M | $0.00 | -$0.782 | 9 |
| Dec 2026 | $10.85M | $4.07M - $15.16M | $0.00 | -$2.245 | 9 |
| Dec 2025 | $1.51M | $525.3K - $3.22M | $0.00 | -$2.267 | 6 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$2.419 | 0 |
| Dec 2020 | $7.92M | $79.7K - $23.87M | $4.75M | -$3.842 | 6 |
| Dec 2019 | $10.71M | $107.8K - $32.28M | $6.43M | -$5.41 | 7 |
| Dec 2018 | $8.52M | $85.7K - $25.67M | $5.11M | -$5.896 | 6 |